Reports for PFIZER CANADA ULC
Company Name
PFIZER CANADA ULC
Totals |
||
Shortage reports |
747 |
|
| Actual shortage: | 83 (11%) | |
| Anticipated shortage: | 10 (1%) | |
| Avoided shortage: | 48 (6%) | |
| Resolved: | 606 (81%) | |
Discontinuation Reports |
87 |
|
| To be discontinued: | 1 (1%) | |
| Discontinued: | 85 (98%) | |
| Reversed: | 1 (1%) | |
Late reports |
20 (2%) |
|
Overdue reports |
9 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MIDAZOLAM INJECTION USP | 1MG | SOLUTION | Resolved | 2019-03-22 | 2019-09-11 | 79211 |
| MIDAZOLAM INJECTION | 1MG | SOLUTION | Resolved | 2019-04-29 | 2019-10-22 | 82597 |
| ATIVAN | 1MG | TABLET | Resolved | 2021-01-18 | 2021-03-26 | 131898 |
| CHAMPIX | 1MG | TABLET | Resolved | 2021-05-06 | 2024-05-02 | 138919 |
| VINBLASTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2021-09-23 | 2021-12-18 | 146133 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2022-01-28 | 2023-02-11 | 153789 |
| ATROPINE SULFATE INJECTION USP | 1MG | SOLUTION | Resolved | 2022-04-18 | 2022-08-11 | 158956 |
| MIDAZOLAM INJECTION USP | 1MG | SOLUTION | Resolved | 2022-05-27 | 2022-07-13 | 161421 |
| ATROPINE SULFATE INJECTION USP | 1MG | SOLUTION | Resolved | 2022-11-01 | 2023-02-04 | 173235 |
| IDARUBICIN | 1MG | SOLUTION | Resolved | 2022-12-02 | 2023-02-11 | 176929 |
| LEVOPHED | 1MG | SOLUTION | Resolved | 2022-12-14 | 2023-01-04 | 178322 |
| MIDAZOLAM INJECTION USP | 1MG | SOLUTION | Resolved | 2023-01-11 | 2023-03-14 | 180728 |
| RAPAMUNE | 1MG | TABLET | Resolved | 2023-01-16 | 2023-02-10 | 181170 |
| VINCRISTINE SULFATE INJECTION USP | 1MG | SOLUTION | Resolved | 2023-04-20 | 2023-10-19 | 189937 |
| VINBLASTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2023-07-21 | 2023-09-07 | 199446 |
| MIDAZOLAM INJECTION USP | 1MG | SOLUTION | Resolved | 2023-08-03 | 2023-10-13 | 200822 |
| IDARUBICIN | 1MG | SOLUTION | Resolved | 2023-08-16 | 2023-12-19 | 201980 |
| IDARUBICIN | 1MG | SOLUTION | Resolved | 2023-09-27 | 2024-01-13 | 205354 |
| ATIVAN | 1MG | TABLET | Anticipated shortage | 2023-11-17 | 2024-04-08 | 210722 |
| ATROPINE SULFATE INJECTION USP | 1MG | SOLUTION | Actual shortage | 2023-12-19 | 2024-01-20 | 213831 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MIDAZOLAM INJECTION | 5MG | SOLUTION | Reversed | 2020-10-07 | 2020-10-19 | 125902 |
| ARICEPT RDT | 5MG | TABLET (ORALLY DISINTEGRATING) | To be discontinued | 2021-04-14 | 2021-04-14 | 137465 |
| ROPIVACAINE HYDROCHLORIDE INJECTION USP | 5MG | SOLUTION | Discontinued | 2022-09-30 | 2022-10-02 | 170502 |
| TRACE ELEMENTS INJECTION USP | 6.0MCG 0.42MG 1.67MG 0.37MG | SOLUTION | Discontinued | 2018-10-09 | 2019-03-13 | 63474 |
| ZYVOXAM 600 MG | 600MG | TABLET | Discontinued | 2020-01-17 | 2022-01-17 | 103480 |
| VIRACEPT | 625MG | TABLET TABLET | Discontinued | 2021-09-03 | 2021-10-29 | 145167 |
| PACLITAXEL FOR INJECTION | 6MG | SOLUTION | Discontinued | 2017-07-11 | 2018-02-01 | 15446 |